(Frigidity or impotence) or (lack or loss of libido) or (psychogen.dyspareunia) or (fear of ejaculation) or (premature ejaculation)
Related entities
Findings (27)
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4
None
improvementAmong 627 women who were sexually active or inactive due to fear of dyspareunia at baseline, dyspareunia decreased from 29.0% to 10.0% at 12 months after pelvic organ prolapse surgery (OR 0.3, 95% CI
Effect: improvement; OR 0.3; CI: 95% CI 0.2 – 0.4